People

Richard Gabriel, BS, MBA Hector J. Gomez, MD, PhD

Co-founder Co-founder

Richard Gabriel, BS, MBA

5 Approved drugs in the market

Richard Gabriel has built and operated several cGMP/GLP drug manufacturing operations, the last employed +160 personnel and generated 5 approved drugs, authored well over 20 CMCs and was instrumental in advancing new technologies and launching spin-out technology companies in computational chemistry, infectious disease treatments, cancer, and neurological drugs.

GLG Pharma is focused on:

Improving patient outcomes through linking single cell cancer technologies to new drug discovery for biomolecules and small molecules.
For helping partners focus on real and deliverable patient benefits and
Turning cancer cell biomarkers into companion diagnostics.

Hector J. Gomez, MD, PhD

11 Approved drugs in the market

Dr. Hector J. Gomez was the first physician scientist to successfully launch a combination drug using global clinical trials and has over 11 approved drugs in the market. Author of presentations of INDs, NDAs that were all successfully approved by the US FDA and EMA as well as many other countries around the world. Dr. Gomez's ability to create, structure, and successfully receive regulatory approvals for the drugs he has chosen as clinical candidates has created billions of dollars for the pharma and biotech companies and programs he has led.

GLG Pharma is focused on:

Selecting the right indications for the right drug combinations that benefit the patient population the most with the least side effects.
For working with clinical partners and biotech and pharma executives with a focus on approvable patient benefits and
Turning cancer combination therapies into leading first line patient treatment therapies.